The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.EBI
National Cancer Institute-Cro
An update on therapeutic opportunities offered by cancer glycolytic metabolism.EBI
University of Pisa
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.EBI
Genentech
Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.EBI
Genentech
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.EBI
Genentech
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase.EBI
Genentech
Dehydrogenase binding by tiazofurin anabolites.EBI
University of Rochester Medical Center
Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer.EBI
Icahn School of Medicine At Mount Sinai
Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.EBI
Genentech
New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production.EBI
Universidad De Granada
Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment.EBI
Sapienza University of Rome
Optimization of ether and aniline based inhibitors of lactate dehydrogenase.EBI
Vanderbilt University
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice.EBI
Genentech
Interrogating the Lactate Dehydrogenase Tetramerization Site Using (Stapled) Peptides.EBI
University of Louvain
Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.EBI
University of New Mexico School of Medicine
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).EBI
National Center For Advancing Translational Sciences
PRPK INHIBITORSBDB
Dana-Farber Cancer Institute
L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsBDB
Recurium Ip Holdings
Cardiac glycoside analogs and their use in methods for inhibition of viral infectionBDB
The John Hopkins University
Aryl- or heteroaryl-substituted benzene compoundsBDB
Epizyme
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitorsBDB
University of Utah
Synthesis and biological evaluation of some new N(4)-substituted isatin-3-thiosemicarbazones.BDB
Bahauddin Zakariya University
Novel behavior of O-methylated beta-cyclodextrins in inclusion of meso-tetraarylporphyrins.BDB
Doshisha University
Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.BDB
Glaxosmithkline